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ABSTRACT 
Polyphenols (PPs) are secondary metabolites abundant in plant-derived foods. They 
are reported to exhibit antimicrobial activity that may offer an alternative to existing 
antimicrobials. The aim of this study was to evaluate the antifungal potential of PPs 
against Candida albicans biofilms that are commonly recalcitrant to antifungal 
therapy. The antifungal activity of 14 PPs was assessed in terms of planktonic and 
sessile minimum inhibitory concentrations (PMICs and SMICs, respectively) against 
various C. albicans clinical isolates. The most active PPs were further tested for their 
effect on C. albicans adhesion and biofilm growth using standard biomass assays, 
microscopy and quantitative gene expression. Of the 14 PPs tested, 7 were effective 
inhibitors of planktonic growth, of which pyrogallol (PYG) was the most effective 
(PMIC50 = 78 g/mL), followed by curcumin (CUR) (PMIC50 = 100 g/mL) and 
pyrocatechol (PMIC50 = 625 g/mL). Both PYG and CUR displayed activity against 
C. albicans biofilms (SMIC50 = 40 g/mL and 50 g/mL, respectively), although they 
did not disrupt the biofilm or directly affect the cellular structure. Overall, CUR 
displayed superior biofilm activity, significantly inhibiting initial cell adhesion following 
pre-coating (P < 0.01), biofilm growth (P < 0.05) and gene expression (P < 0.05). 
This inhibitory effect diminished with prolonged CUR exposure, although it still 
inhibited by 50% after 4 h adhesion. Overall, CUR exhibited positive antibiofilm 
properties that could be used at the basis for development of similar molecules, 
although further cellular and in vivo studies are required to explore its precise 
mechanism of action. 
1. Introduction 
Candida albicans is an opportunistic fungal pathogen most commonly associated 
with superficial infections of the oral cavity, although in immunocompromised 
individuals it can cause life-threatening forms of invasive candidiasis [1]. An 
important contributing factor in C. albicans pathologies is its flexibility in adapting to 
different environmental conditions by virtue of its morphological plasticity that 
enables growth preferentially as biofilms, which provides protection both from host 
defences and antimicrobial therapies [2]. Therefore, alternative approaches to 
manage and impede these infections more effectively are highly desirable. 
 
Recently, natural compounds have been reported to demonstrate antibiofilm activity 
[3], which is important given that the likelihood of developing resistance to these 
molecules is low. Therefore, harnessing and exploiting the chemical diversity 
provided by Mother Nature’s larder as a means of combating oral candidal infections 
is an attractive option [4]. Polyphenols (PPs) are an abundant source of 
macromolecular structures containing phenolic hydroxyl rings that can be found in 
various diets naturally, but are also found as synthetic and semisynthetic 
compounds. The aim of this study was to explore the possibility that PPs prevent 
growth and biofilm formation by C. albicans. We report for the first time the antifungal 
activity of specific PPs with biofilm inhibitory potential, acting through modulation of 
proteins responsible for adhesion and biofilm formation. 
 
2. Materials and methods 
2.1. Strains and culture conditions 
Candida albicans reference strains MYA-2876 (SC5314) and MYA-4788 (3153A) as 
well as a range of oral (n = 6), denture (n = 6) and bloodstream (n = 6) clinical 
isolates from the culture collection of Glasgow Dental School (University of Glasgow, 
Glasgow, UK) were used in this study, which were confirmed using an API® 32C 
biochemical testing panel (bioMérieux UK Ltd., Basingstoke, UK). Isolates were 
propagated in yeast–peptone–dextrose medium (Oxoid Ltd., Cambridge, UK), 
washed in phosphate-buffered saline (PBS) (Sigma-Aldrich, Poole, UK) by 
centrifugation and then re-suspended in RPMI 1640 medium (Sigma-Aldrich). 
 
2.2. Planktonic and sessile antifungal sensitivities 
Fourteen high-performance liquid chromatography (HPLC)-grade PP compounds 
purchased from Sigma-Aldrich were used in this study (Table 1). Depending on their 
solubility, fresh stock concentrations of each PP compound were prepared either in 
double-distilled water or dimethyl sulphoxide (DMSO). Dilutions of the stock were 
made in RPMI 1640 medium, with the final concentration of DMSO adjusted to <5% 
v/v. The antifungal activity of these PPs against 20 C. albicans was evaluated in 
terms of their planktonic minimum inhibitory concentration (PMIC) and planktonic 
minimum fungicidal concentration (MFC) by the broth microdilution method following 
Clinical and Laboratory Standards Institute (CLSI) guidelines [5]. The PMIC was 
defined as the lowest concentration of PP that inhibited visible growth, and the MFC 
was determined as the lowest concentration giving no visible growth from culture 
medium transferred to Sabouraud dextrose agar (Sigma, Poole, Dorset, UK). Sessile 
minimum inhibitory concentrations (SMICs) were defined as a ≥50% reduction in 
metabolic activity compared with the untreated control [3]. The PMIC50, PMFC50 and 
SMIC50 were defined as the concentrations at which the median number of isolates 
tested was inhibited, killed or metabolically reduced, respectively. 
 
2.3. Evaluating the physical effects of polyphenols 
To assess the effect on membrane integrity, a propidium iodide (PI) uptake assay 
was performed. Candida albicans SC5314 was standardised in RPMI 1640 medium 
to 1  107 cells/mL in a haemocytometer as described in our previous study [3]. Cells 
were then treated with 4 SMIC50 of the two most effective PPs [curcumin (CUR) and 
pyrogallol (PYG)] every 10 min over 1 h. As a positive control, 70% ethanol (Sigma, 
Poole, Dorset, UK) was used. Following individual treatments, cells were centrifuged, 
washed in PBS and stained with PI (20 M) for 15 min in darkness. PI uptake was 
then quantified by transferring 100 L of the solution into a Corning® Costar® flat-
bottom, 96-well, black microtitre plate (Sigma, Poole, Dorset, UK) and measuring 
fluorescence at excitation and emission wavelengths of 535 nm and 617 nm, 
respectively, using a microplate reader (FLUOstar Omega; BMG Labtech, Aylesbury, 
Buckinghamshire, UK). To assess biofilm disruption, an established crystal violet 
(CV) biomass assay was performed [3]. Briefly, C. albicans SC5314 biofilms were 
grown for 24 h and were treated with CUR and PYG for 24 h, after which these were 
washed with PBS, air-dried and stained with 0.05% w/v CV (Sigma, Poole, Dorset, 
UK) for 20 min, and then quantified by destaining with 100% ethanol and measuring 
the absorbance at 570 nm (Tecan SunriseTM; Jencons, East Grinstead, UK). 
Scanning electron microscopy was also performed on treated C. albicans SC5314 
and untreated controls as previously described [3]. 
 
2.4. Gene expression analysis of biofilm-associated genes 
The effect of PPs on C. albicans SC5314 adhesion (als3) and filamentation (hwp1) 
was analysed by quantitative transcriptional analysis. Standardised cells (1  108 
cells/mL) were placed in a 50 mL tube on an orbital shaker (200 rpm) at 37 C in the 
presence of CUR or PYG at 1 SMIC50 concentrations, or in RPMI alone, for 
durations of 1, 4 and 24 h, in triplicate. At each time point, cells were removed, 
washed by centrifugation with PBS, and RNA was extracted using the TRIzol® 
method (Invitrogen, Paisley, UK) [6]. After DNase treatment (QIAGEN, Crawley, UK) 
and purification (RNeasy MinElute Cleanup Kit; QIAGEN), cDNA was synthesised 
using a High-Capacity RNA-to-cDNATM Kit (Life Technologies, Paisley, UK), and 
quantitative PCR (qPCR) was performed using a SYBR® GreenERTM assay (Life 
Technologies Ltd.). The primers and conditions used for real-time quantitative 
polymerase chain reaction (RT-qPCR) throughout this study are described 
elsewhere [7]. Each parameter was analysed in duplicate using an MxProP 
Quantitative PCR machine and MxProP 3000 software (Stratagene, Amsterdam, The 
Netherlands). Gene expression was normalised to the housekeeping gene act-1 
according to the 2−ΔΔCT method, and the percentage of gene expression was 
expressed as the log10 mean ± standard deviation [8]. 
 
2.5. Evaluating the effect of polyphenols on Candida albicans biofilm development 
ThermanoxTM coverslips (Nunc Inc., Thermo Fisher Scientific, Paisley, UK) were 
placed in a Corning® Costar® 24-well, flat-bottom plate (Sigma, Poole, Dorset, UK) 
containing SMIC concentrations of CUR or PYG and were incubated overnight at 4 
C. Unbound compound was removed prior to adding 500 L of standardised 
suspensions of C. albicans SC5314 (1  106 cells/mL) and allowing them to adhere 
for 30 min at 37 C. Following incubation, coverslips were gently washed in PBS and 
were transferred to a glass slide for quantification of cell numbers under a light 
microscope (Model BX40F4; Olympus, Shinjuku, Tokyo, Japan) at 40 
magnification. Cells were counted manually from three separate fields, averaged, 
and the cell count for the whole surface area of the coverslip was calculated. The 
effect of CUR and PYG on hyphal growth and on the initial stages of biofilm 
formation were also evaluated by plating a standardised (1  106 cells/mL) C. 
albicans suspension in 96-well, flat-bottom microtitre plates. At 0, 1, 2 and 4 h post 
adhesion, cells were treated with a 1 SMIC50 concentration of CUR or PYG and 
were incubated for a further 24 h at 37 C. The resultant biofilm biomass was 
quantified using the CV assay and was compared with untreated controls. This 
experiment was performed on two independent occasions using six replicates of 
each strain (n = 5). 
 
2.6. Statistical analysis 
Data distribution and statistical analysis were performed using GraphPad Prism v.5 
(GraphPad Software Inc., La Jolla, CA). Unpaired t-test was used to assess the 
difference between two independent samples. Student’s t-test was employed to 
measure statistical differences between the time points assessed in gene expression 
studies. One-way analysis of variance (ANOVA) with Tukey’s post-hoc test was used 
on data obtained from the PI uptake assay and biofilm inhibition assay. 
 
3. Results 
3.1. Curcumin and pyrogallol possess antifungal activity against Candida albicans 
In total, 14 PPs were tested for their antifungal potential against C. albicans (Table 
1). Seven PPs were shown to be effective at inhibiting planktonic growth of C. 
albicans (CUR, PYG, pyrocatechol, quercetin, gallic acid, caffeic acid and 
naringenin). PYG (PMIC50 = 78 g/mL) and CUR (PMIC50 = 100 g/mL) were the 
most effective, showing dose-dependent inhibition of growth at 1, 2 and 4 MIC 
(data not shown). The remaining compounds showed no discernible effect on 
planktonic growth, both with respect to inhibition (PMIC) and killing (PMFC). The 
PMFC generally ranged from 2–8-fold higher than the PMIC for PYG and CUR. 
 
Of all the PPs, PYG and CUR displayed potent activity against sessile C. albicans 
(Table 1), with PYG being more effective (SMIC50 = 39.06 g/mL) than CUR (SMIC50 
= 50 g/mL), although neither of these compounds could significantly reduce and 
disrupt biofilm biomass [88.76% (P = 0.19) and 87.27% (P = 0.29), respectively] 
compared with the control (100%). The remaining PPs tested displayed relatively 
poor antifungal activity against sessile growth of the test strains, with all growing at 
concentrations exceeding the maximum solubility of each PP. Therefore, on this 
basis, all further testing was performed only with only PYG and CUR. It was also 
shown that neither PYG or CUR had any discernable effects of membrane integrity 
using a PI uptake assay, where neither showed any significant PI uptake over 1-h 
exposure of compound, whereas significant PI uptake was observed after 10 min for 
ethanol-treated cells (P < 0.001). 
 
3.2. Curcumin and pyrogallol affect Candida albicans biofilm development 
We investigated whether transcription of genes involved in adhesion and hyphal 
formation, critical factors for the development of C. albicans biofilms [9], were 
impacted by CUR and PYG treatment using qRT-PCR. Expression of the adhesin 
als3 was shown to be significantly downregulated by CUR at 1 h (P < 0.05) and 24 h 
(P < 0.001), whereas PYG showed no significant downregulation of als3 (P > 0.05) 
following treatment (Fig. 1). These effects were also evaluated using phenotypic 
assays, where it was demonstrated that pre-coating coverslips with CUR significantly 
reduced C. albicans adhesion by 55.3% (P < 0.01), whereas PYG coating only led to 
a slight reduction in adhesion of 15.63% (P > 0.05). Analysis of the filamentation-
associated gene hwp1 showed a significant downregulation for CUR at all time 
points tested (1 h, P < 0.01; 4 h, P < 0.05; 24 h, P < 0.001). In contrast, PYG did not 
significantly alter hwp1 expression, although a 16-fold downregulation was observed 
at 4 h (Fig. 1). Microscopy analysis confirmed this, where both PYG and CUR can 
clearly be observed to impede filamentation and biofilm formation (Fig. 2A). 
 
The effect of delayed treatment on C. albicans biofilm formation was also explored. 
Fig. 2B illustrates that compared with the untreated control cells, both CUR and PYG 
were able to significantly reduce biofilm biomass when added at 0, 1, 2 (P < 0.001) 
and 4 h (P < 0.01) post adhesion. These effects were shown to diminish the longer 
C. albicans was permitted to colonise, form hyphae and initiate biofilm formation. 
CUR was shown to inhibit biofilm development by 80% following early co-incubation 
(0 h), although this was significantly reduced to 50% if added 4 h post inoculation (P 
< 0.05). PYG was less effective, inhibiting biofilm development by 70% initially at 0 h, 
but only by 20% after 4 h. Significant differences between the two compounds were 
observed at 2 h (P < 0.01) and 4 h (P < 0.05). 
 
4. Discussion 
The past two decades have witnessed a significant increase in the prevalence of 
multidrug-resistant C. albicans strains, which is partly due to increased usage of 
conventional antifungal agents along with a rise in the number of 
immunocompromised individuals [1]. Here we report the potential for PPs to be used 
against planktonic and sessile growth of clinically important C. albicans. We have 
shown that CUR and PYG were the most active of the tested PPs, inhibiting growth 
and biofilm formation of C. albicans via suppression of genes responsible for 
adhesion and hyphal growth. To the best of our knowledge, this is the first study to 
explore the antifungal potential of PP compounds (flavonoids and non-flavonoids) 
both against planktonic and biofilm growth of C. albicans laboratory and clinical 
isolates. 
 
Of all the PPs tested, CUR and PYG possess the greatest antifungal activity against 
planktonic C. albicans cells including both clinical and laboratory isolates, as 
evidenced by their lower MIC values. This was largely in agreement with other 
studies [10], although published data on PYG is limited. In fact, data in the current 
study showed lower MIC values compared with previous studies (>180 g/mL) [11]. 
This may have been due to intra-assay variation, including methodology, purity and 
source of PPs, and fungal strains used. The most notable feature of this study was 
the activity against biofilms. Both CUR and PYG compounds effectively killed sessile 
C. albicans, although they showed no direct physical effects per se when evaluated 
through membrane disruption and microscopically at high concentrations. Others 
have suggested that prolonged exposure at high concentrations (185 g/mL) 
permeabilises membranes and disrupts cell wall integrity {Kumar, 2013 #10}, 
although we did not test these concentrations in this study. 
 
Although PYG numerically has lower MICs, these are very minor compared with 
CUR, which may be a limitation of broth microdilution testing. The superior inhibitory 
activity of CUR in the subsequent biofilm assays may be attributed to its chemical 
structure. Compared with PYG (containing only one phenol group in its structure), 
CUR has two phenol groups connected by two ,-unsaturated carbonyl groups. In 
addition, the presence of two unsaturated double bonds in the central connecting 
chain may further potentiate its activity [13], although further studies are required to 
elucidate the precise mechanism. Notably, downregulation of key biofilm genes, 
such as the adhesin als3 and the hyphal protein hwp1, explains the impeded biofilm 
phenotype. Delay in exposure to these molecules has a negative impact on the 
effectiveness of the PPs. Despite this, it has been shown that CUR possess 
synergistic potential with other antifungal compounds [11], suggesting that these 
could be used to augment the treatment of oral candidosis for example. 
 
PPs are ubiquitous in plant foods, with CUR readily available in common foods such 
as dried turmeric and curry powder. However, intake, bioavailability and safety 
assessments are important considerations. PYG is available in low amounts in cocoa 
products, coffee and beer, and whilst the brief exposure of the oral mucosa to PPs 
during food intake may not be sufficient for potential therapeutic purposes, their high 
affinity for surface adsorption, including oral tissues, may be important [14]. 
Moreover, although bioavailability of PPs may be low, some PP metabolites may 
also appear in saliva, adding to their overall localised bioactivity in the oral cavity. 
CUR has been shown to possess adsorption potential and has been extensively 
used for controlled delivery of protein molecules [15]. Adsorption properties can be 
employed in increasing the local (oral) availability of CUR at the site of action and 
preventing initiation of biofilm formation on tissue surfaces and prosthetic devices. 
 
Pharmaceutically and dietary, there are clear opportunities for the development of 
oral care products containing PPs. Whilst CUR and similar PPs are tantalising 
targets for development owing to their natural background, further cellular studies 
are required to progress these molecules for the treatment and prevention of fungal, 
and possibly bacterial, diseases in humans. 
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Table 1| Activity of polyphenols against planktonic and sessile Candida albicans 
Test polyphenol Solvent Stock 
(g/mL) 
Test range 
(g/mL) 
Minimum inhibitory concentration (g/mL) 
PMIC PMFC SMIC 
PMIC50 
a 
Range PMFC50 
a
 Range SMIC50 
a
 Range 
Epigallocatechin ddH2O 2000 0.976–500 >500 ˃500 ˃500 ˃500 ˃500 ˃500 
Epigallocatechin gallate ddH2O 2000 1.95–1000 >1000 ˃1000 ˃1000 ˃1000 ˃1000 ˃1000 
Curcumin DMSO 2000 0.19–100 100 12.5 to >100 >100 100 to ˃100 50 12.5 to >100 
Apigenin DMSO 1000 7.81–125 ˃125 ˃125 ˃125 ˃125 ˃125 ˃125 
Hesperetin DMSO 5000 0.976–500 ˃500 ˃500 ˃500 ˃500 ˃500 ˃500 
Naringenin DMSO 5000 0.976–500 ˃500 500 to ˃500 ˃500 ˃500 ˃500 ˃500 
Pyrocatechol ddH2O 10000 9.76–5000 625 312.5–5000 2500 625–5000 2500 312.5 to ˃5000 
Pyrogallol ddH2O 10000 9.76–5000 78.12 19.53–625 635 156.2 to ˃5000 39.06 9.76–156.25 
Gallic acid ddH2O 10000 9.76–5000 ˃5000 2500 to ˃5000 ˃5000 2500 to ˃5000 ˃5000 ˃5000 
3,4-dihydroxyphenylacetic acid ddH2O 10000 9.76–5000 ˃5000 ˃5000 ˃5000 ˃5000 ˃5000 ˃5000 
Caffeic acid DMSO 2000 1.95–1000 >1000 1000 to >1000 >1000 1000 to >1000 >1000 >1000 
Quercetin DMSO 2000 0.39–200 >200 50 to >200 >200 100 to >200 >200 >200 
Malvidin ddH2O 1000 0.976–500 ˃500 ˃500 ˃500 ˃500 ˃500 ˃500 
Pelargonidin DMSO 5000 4.88–2500 ˃2500 ˃2500 ˃2500 ˃2500 ˃2500 ˃2500 
ddH2O, double-distilled water; DMSO, dimethyl sulphoxide; PMIC, planktonic minimum inhibitory concentration; PMFC, planktonic minimum fungicidal 
concentration; SMIC, sessile minimum inhibitory concentration. 
a
 The PMIC50, PMFC50 and SMIC50 represent the concentration at which the median number 
of strains from a total of 20 were either inhibited (planktonic), killed (fungicidal) or their metabolic activity was reduced by 50% (sessile). 
 
 
 
Fig. 1. Effect of curcumin (CUR) and pyrogallol (PYG) on expression of Candida 
albicans adhesin (als3) and hyphal (hwp1) genes. Standardised C. albicans SC5314 
(1  108 cells/ml) was grown for 1, 4 and 24 h in ±1 SMIC50 of CUR or PYG in RPMI 
1640 medium. RNA was extracted and purified for quantitative RT-PCR analysis and 
expression of als3 and hwp1 using act-1 as a housekeeping gene. Error bars 
represent the standard error of mean. * P < 0.05; ** P < 0.01; *** P < 0.001. 
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Fig. 2. Effect of pre-exposure to curcumin (CUR) and pyrogallol (PYG) on Candida 
albicans biofilm formation. Standardised C. albicans (1  106 cells/mL) were added to 
either ThermanoxTM coverslips pre-coated with 1 SMIC of CUR and PYG or to a 96-
well, flat-bottom plate treated with ±1 SMIC50 of CUR and PYG at 0, 1, 2, and 4 h 
post adhesion and allowed to grow for a further 24 h. The resultant biofilm was 
assessed (A) visually by scanning electron microscopy or (B) the biomass was 
quantified using five isolates on two independent occasions (n = 6). Error bars 
represent the standard error of mean. (** P < 0.01;* P < 0.05). 
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